Antonio Matrone

35PUBLICATIONS
25CO-AUTHORS
Nanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Jul 23, 2026
Impairment in the hypothalamic-pituitary-gonadal axis in males with medullary thyroid carcinoma treated with selpercatinib.

|May 12, 2026
18F-DOPA-PET/CT role in medullary thyroid cancer patients with biochemical incomplete response.

|Mar 27, 2026
Molecular Profile of Advanced Radioiodine-refractory Thyroid Cancer and Response to Lenvatinib Treatment.

Elisa Minaldi, Teresa Ramone, Raffaele Ciampi

|Feb 25, 2026
Fatal tracheal perforation following Dabrafenib-Trametinib therapy in BRAF V600E-mutant mixed anaplastic thyroid cancer.

Antonio Matrone, Marianna Scordo, Elisa Minaldi

|Feb 14, 2026
Calcitonin thresholds for prediction of medullary thyroid carcinoma and its clinical response in MEN2A gene carriers.

Alessandro Prete, Antonio Matrone, Cristina Romei

|Mar 28, 2025
Body Mass Index and Sporadic Medullary Thyroid Cancer: Insights from a Large Series.

Alessandro Prete, Carla Gambale, Valeria Bottici

Pageof 6

Frequent Collaborators

24 joint publications

Rossella Elisei

8 joint publications

Cristina Romei

7 joint publications

Alessandro Prete

6 joint publications

Raffaele Ciampi